Heather A. Wakelee, MD

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity

Research’s Race to Stop a Pandemic

Impactful Multidisciplinary Care Not Out of Reach in Community Settings

CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients With Lung Cancer

EGFR/ALK-Mutated NSCLC: Using Real-world Therapeutic Practices to Help Answer Real-world Therapeutic Questions

Increasing Understanding about the Role Biosimilar Agents in Everyday Practice: A Q&A with Dr. Gary Lyman (Part 1 of 2) 

Leora Horn, MD, MSc, FRCPC

Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP

Interstitial Lung Abnormality, Interstitial Lung Disease, and Lung Cancer

Alexander Drilon, MD